Our results displayed that the immune checkpoints including PD-L1, PD1, TIGIT, TIM3, and CTLA4 were significantly highly expressed in the high CRFCS group compared with the low CRFCS group in both TCGA and ICGC HCC cohorts (Figures 6C, D). The gene discussed is CTLA4; the disease is hepatocellular carcinoma.